Namita Seth Mohta, MD
Executive Editor, NEJM Catalyst Innovations in Care Delivery, NEJM Group
Namita Seth Mohta is a physician executive with expertise in health care delivery transformation. As the executive editor for NEJM Catalyst Innovations in Care Delivery, she is part of the founding leadership team and has responsibility for content strategy
and quality. Most recently, Dr. Mohta served as the director of the Serious Illness Care Program (SICP) at Ariadne Labs, a health system innovation center at Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health. The SICP
is focused on the design, test, and spread of solutions to improve care for patients and caregivers experiencing serious illness. Dr. Mohta has been part of the founding Population Health and ACO leadership teams as medical director, both at Partners
HealthCare (now Mass General Brigham) and the New England Quality Care Alliance (Tufts Medical Center), both in Boston. Her responsibilities have included designing and implementing value-based care with a focus on scaling tailored clinical interventions,
integrating analytics and measurement, and leading system-wide change management efforts. Dr. Mohta has worked with multiple start-ups, including PatientPing (now Bamboo Health), a digital health company, as their physician lead, with a focus on building
products that improve care. She often consults with organizations to provide strategic and technical expertise and leadership. She worked as a management consultant with the Boston Consulting Group prior to medical training.
Dr. Mohta practices internal medicine as a hospitalist at Brigham and Women’s Hospital and is assistant professor in the Department of Medicine at Harvard Medical School. Dr. Mohta is former faculty at the Center for Healthcare Delivery Sciences and current
associate faculty at Ariadne Labs. She completed her internal medicine and primary care residency training at Brigham and Women’s Hospital. Dr. Mohta is a graduate of Yale College and Yale School of Medicine.
Ami B. Bhatt, MD, FACC
Chief Innovation Officer, American College of Cardiology
Associate Professor, Harvard Medical School
Ami B. Bhatt is the chief innovation officer (CIO) at the ACC and an associate professor at Harvard Medical School. Her interest in digital health strategy and the digital transformation of the cardiovascular field stems from the belief that state of the art, personalized care can be delivered to individuals in the community, empowering patients and creating stronger patient-clinician partnerships for sustainable health outcomes. The ACC Innovation Program has a robust platform to transform digital patient care and advance technologies that are reshaping medicine.
Dr. Bhatt has 20 years of experience as a clinician, investigator, and educator with nearly 10 years of experience in telemedicine and digital health. She founded her first program in cardiovascular virtual care in 2013 and continues to work on creating culturally relevant personalized virtual cardiovascular care delivery models. Her research has centered on identifying and implementing solutions to overcoming access barriers to cardiovascular and telemedicine care.
A graduate from Harvard College and the Yale School of Medicine, Bhatt completed her medicine and pediatrics residency, and cardiovascular fellowships at Harvard, Brigham and Women’s Hospital, and the Children’s Hospital of Boston. She was the inaugural Richard Liberthson Endowed Scholar in Adult Congenital Heart Disease (ACHD) at the Massachusetts General Hospital while Director of their ACHD program. She most recently served as the director of Outpatient and Telecardiology at the Massachusetts General Hospital Corrigan-Minehan Heart Center.
The ACC Innovation Program leads co-development with cardiovascular technology companies with a focus on implementation in clinical practice, collaborates with medical societies in the US and globally to create technical frameworks for the digital transformation of health care, and offers though leadership and insights to industry partners and investment firms ensuring cross industry collaboration as we modernize health care for better patient experience and outcomes, medical system and population health efficiency and clinician well-being.
Niteesh K. Choudhry, MD, PhD
Professor of Medicine, Harvard Medical School
Professor in Health Policy and Management, Harvard T.H Chan School of Public Health
Associate Director, Postgraduate Education and Director, Implementation Research and Education, Harvard Catalyst, Harvard Medical School
Associate Physician, Division of Pharmacoepidemiology and Pharmacoeconomics and the Hospitalist Service, Brigham and Women's Hospital
Niteesh K. Choudhry is Professor of Medicine at Harvard Medical School, Professor in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health and Executive Director for the Center for Healthcare Delivery Sciences (C4HDS) at Brigham and Women’s Hospital, where he also a practicing hospitalist. Through C4HDS, he directs the Roybal Center for Therapeutic Optimization using Behavioral Science and co-directs the Massachusetts Artificial Intelligence and Technology Center (MAITC), both of which are funded by the NIH/NIA.
Dr. Choudhry’s research combines techniques from behavioral and data science to develop and test solutions to improve health care quality for common health care conditions such as heart disease and diabetes. His largest projects focus on improving the quality of medication prescribing and long-term adherence. He has run numerous pragmatic trials testing a variety of potential interventions to address these issues in partnership with large delivery systems and health insurers around the U.S.
Dr. Choudhry attended McGill University, received his M.D. and completed his residency training in Internal Medicine at the University of Toronto and then served as Chief Medical Resident for the Toronto General and Toronto Western Hospitals. He earned his Ph.D. in Health Policy from Harvard University with a concentration in Statistics and the Evaluative Sciences and was concurrently a Post-Doctoral Fellow in Drug Policy Research at Harvard Medical School. His research has published over 275 papers in leading medical and policy journals and has won numerous awards for excellence in research, teaching and mentorship.
Lee Schwamm, MD
C. Miller Fisher Chair in Vascular Neurology and Director, MGH Center for TeleHealth, Massachusetts General Hospital
Vice President, Digital Patient Experience & Virtual Care, Mass General Brigham
Professor of Neurology, Harvard Medical School
Lee H. Schwamm, MD, is Professor of Neurology at Harvard Medical School, holds the C. Miller Fisher Chair in Vascular Neurology, and is director of the Center for TeleHealth at Massachusetts General Hospital. He is currently the chief digital advisor at Mass General Brigham Health System, and previously served as vice president of Digital Patient Experience, leading all systemwide virtual care (telehealth) activities, including synchronous and synchronous virtual visits and consults, remote patient monitoring, virtual urgent care, and online second opinions.
During the first six months of COVID, he led adoption efforts for 10,000 clinicians to provide over 1.7 M virtual visits and introduced a suite of innovative inpatient virtual solutions. Dr. Schwamm has spent 2 decades in telehealth, as a pioneer in telestroke and a leading advocate for the American Heart Association (e.g., FAST Act in Congress). He is an internationally recognized expert in stroke diagnosis, treatment and prevention, and a Fellow of the American Heart Association, American Academy of Neurology, and the American Neurological Association. He is the author of >500 peer-reviewed articles and has chaired many of the current practice guidelines for stroke and telehealth-enabled care delivery.
Dr. Schwamm has received numerous awards for innovation, leadership, and advocacy in the field of stroke and digital health and held many senior leadership positions within the AHA and served on their National Board of Directors. He serves as the section editor for digital health for Stroke, and on the international advisory board for Lancet Digital Health. His research has been funded by NIH, PCORI, AHRQ, HRSA, CDC, and others.
